SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-182967
Filing Date
2021-06-04
Accepted
2021-06-04 16:29:19
Documents
13
Period of Report
2021-06-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d120581d8k.htm   iXBRL 8-K 25147
  Complete submission text file 0001193125-21-182967.txt   189270

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pana-20210601.xsd EX-101.SCH 4148
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pana-20210601_def.xml EX-101.DEF 14356
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pana-20210601_lab.xml EX-101.LAB 23787
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pana-20210601_pre.xml EX-101.PRE 15390
6 EXTRACTED XBRL INSTANCE DOCUMENT d120581d8k_htm.xml XML 5612
Mailing Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103
Business Address 357 TEHAMA STREET, FLOOR 3 SAN FRANCISCO CA 94103 (415) 754-3517
Nuvation Bio Inc. (Filer) CIK: 0001811063 (see all company filings)

IRS No.: 850862255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39351 | Film No.: 21996851
SIC: 2834 Pharmaceutical Preparations